Prestige BioPharma Limited (KRX:950210)
South Korea · Delayed Price · Currency is KRW 12,350
-200 (-1.59%)
At close: Dec 26, 2025
Prestige BioPharma Market Cap
Prestige BioPharma has a market cap or net worth of 148.44 billion as of December 26, 2025. Its market cap has decreased by -17.23% in one year.
Market Cap
148.44B
Enterprise Value
231.10B
Revenue
14.41B
Ranking
n/a
PE Ratio
47.07
Stock Price
12,350.00
Market Cap Chart
Since May 28, 2021, Prestige BioPharma's market cap has decreased from 360.58B to 148.44B, a decrease of -58.83%. That is a compound annual growth rate of -17.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 148.44B | -18.27% |
| Dec 30, 2024 | 181.61B | 59.39% |
| Dec 28, 2023 | 113.94B | 29.33% |
| Dec 29, 2022 | 88.10B | -64.84% |
| Dec 30, 2021 | 250.60B | -30.50% |
| May 28, 2021 | 360.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 78.32T |
| Celltrion | 39.38T |
| ALTEOGEN | 23.48T |
| ABL Bio | 10.97T |
| SK Biopharmaceuticals | 9.80T |
| Yuhan | 8.41T |
| LigaChem Biosciences | 6.55T |
| HLB Co., Ltd. | 6.06T |